As the countdown to Nvidia's earnings accelerates, the broader AI supply chain is fracturing under heavy selling pressure. Optical components and memory names are bearing the brunt of pre-market de-risking today, creating sharp trading setups while capital simultaneously rotates into tariff-protected US cyclicals.
BHP Group Ltd shares surged to a record intraday high of $67.72 on Monday, August 24, as spot copper rose 1.8% to US$6.68 per pound. The breakout follows FY26 financial results confirming copper has officially surpassed iron ore as BHP's largest earnings contributor, generating US$18 billion in underlying EBITDA and driving net profit up 9% to US$9.83 billion. The rally was further supported by supply disruptions at Zijin Mining's Kamoa-Kakula complex, where 2026 output could drop by 57,000 tonnes due to flooding and seismic issues.
Why it matters
The structural shift in BHP's earnings composition marks a genuine fundamental story change, transforming the diversified miner into a premier mega-cap copper proxy. With global mine-supply disruptions tightening physical markets just as AI power grid demand ramps, BHP's breakout from multi-month consolidation confirms heavy institutional sponsorship. Swing traders should watch for continuation opportunities on shallow pullbacks toward the breakout level.
FirstCash Holdings Inc. (FCFS) shares climbed 6.09% on Monday, August 24, after Loop Capital upgraded the stock from Hold to Buy and raised its price target to $255 from $220. The upgrade was backed by proprietary survey data demonstrating accelerating consumer demand for pawn loans and retail merchandise in a sticky inflation setting. FCFS trades in the mid-$230s following quarterly revenues of $1.07 billion and gross margins exceeding 50%.
Why it matters
FirstCash is executing a classic counter-cyclical breakout, benefiting directly from persistent inflation pressures on middle- and lower-income consumers. Loop's target hike to $255 provides a clear valuation runway, driving institutional buying out of a multi-week consolidation base. Traders should track FCFS as a high-relative-strength defensive compounder that diverges positively from broader market volatility.
Nvidia (NVDA) traded down 1.04% to $212.48 ahead of its fiscal Q2 earnings report on Wednesday, August 26, where consensus expects $91.91 billion in revenue and $2.07 adjusted EPS. Options markets are pricing a 5.35% implied post-earnings move, representing roughly $280 billion in market value swing. Meanwhile, component and optical suppliers experienced heavy selling on Monday, August 24, with Applied Optoelectronics (AAOI) dropping over 12% on co-packaged optics (CPO) shift fears, Micron (MU) falling 5.83%, and Broadcom (AVGO) shedding 2.63%. Buy-side focus centers on whether Nvidia's Q3 guidance can exceed the $103 billion to $105 billion whisper threshold.
Why it matters
The stark divergence between Nvidia's modest pre-earnings consolidation and the violent liquidations across its supply chain signals acute institutional sensitivity to order timing and input price inflation. Suppliers like AAOI, MU, and AVGO are absorbing the brunt of pre-earnings de-risking, creating potential mean-reversion setups if Nvidia's guidance validates ongoing datacenter capital expenditure. For intraday and swing traders, watching whether NVDA reclaims its $214 pivot or breaches the $208.90 double-top support floor will dictate broad market direction.
As the collapse in Washington-Ottawa trade talks cements the 50% U.S. tariffs on Canadian goods we tracked yesterday, domestic steel producers rallied sharply on Monday. The preserved tariff moat triggered single-session surges in Cleveland-Cliffs (CLF +7.1%), Nucor (NUE +4.3%), and Steel Dynamics (STLD +5.0%). Domestic benchmark hot-rolled band prices remain elevated at $1,208 per metric ton, vastly outperforming global benchmarks and driving up quarterly operating income expectations.
Why it matters
The breakdown in negotiations provides a powerful protective moat for domestic electric-arc furnace steelmakers, expanding operating margins at the direct expense of consuming industries. STLD's move back above $240 reclaims key technical levels, offering momentum setups as capital rotates into tariff-sheltered cyclicals. However, traders must continue to monitor headline risk as Canada's dollar-for-dollar retaliatory measures loom for September 8.
Sadot Group Inc. (SDOT) shares spiked nearly 90% in midday trading on Tuesday, August 25, reaching $24.98 amid extreme volatility. The move was fueled by balance-sheet restructuring that extinguished $1.08 million in debt via equity issuances at $8 per share, paired with $1 million in preliminary July gross revenue from its AI-powered TradeOS platform. Intraday price swings were heavily amplified by a low float structure following a 1-for-20 reverse stock split earlier this year.
Why it matters
Sadot presents a classic low-float parabolic setup driven by a business-model pivot toward AI software. While debt cleanup and initial software revenue provide short-term momentum triggers, low cash reserves and heavy potential equity dilution make this a prime candidate for short-side exhaustion once buying volume dries up. Day traders must monitor float dynamics and intraday volume climax signals for reversal setups.
Regenxbio (RGNX) shares tumbled 25% in premarket trading on Monday, August 24, following an FDA clinical hold on its Phase 1/2/3 CAMPSIITE study for Hunter syndrome asset RGX-121. The regulatory action was triggered by the discovery of small nodules or cystic masses in spine MRIs across five trial participants. Regenxbio announced it no longer expects to resubmit its Biologics License Application (BLA) in the near term, reversing regulatory momentum achieved earlier in the summer.
Why it matters
The sudden clinical hold introduces severe binary downside, breaking the stock's multi-week base structure and completely invalidating near-term commercial timelines. Because the spinal masses were detected via expanded MRI protocols following a prior hold on RGX-111, institutional investors face platform-wide delivery safety concerns regarding AAV vector routes. For tactical traders, this is a clear short-side continuation setup and a warning against holding high-beta biotech catalysts into unhedged regulatory reviews.
Capricor Therapeutics (CAPR) shares jumped 13.75% on Monday, August 24, following confirmation that the FDA agreed to review an amended BLA for lead asset deramiocel in Duchenne muscular dystrophy using 24-month HOPE-3 extension data. Concurrently, the FDA extended the PDUFA target action date from August 22 to November 22, 2026, to allow time for the review. Cantor Fitzgerald upgraded CAPR to Overweight, aggressively raising its price target to $28 from $3.50, while activist firm Kaos Capital pushes the board for strategic alternatives.
Why it matters
The FDA's agreement to review the amended BLA unwinds prior advisory committee concerns, reopening an accelerated regulatory pathway for deramiocel. Cantor's target hike to $28 represents an extraordinary sell-side re-rating that provides tailwinds for swing traders. Despite the PDUFA date being pushed to November 22, activist pressure and $237.9 million in cash establish a firm floor for event-driven positioning.
Following the BMO Capital target hike to $550 we just covered, Raymond James is now piling in, upgrading Advanced Micro Devices (AMD) to Strong Buy and raising its price target from $565 to $641. Senior analyst Srini Pajjuri outlined an 'AI Factory' framework projecting a 44% compound annual growth rate for AMD's datacenter revenue through 2030, reaching $201 billion. The bullish chorus builds on the Q2 2026 print we've been tracking, where AMD's Data Center segment expanded 107% year-over-year.
Why it matters
This tier-1 target hike provides a fresh fundamental catalyst for an episodic pivot setup, countering recent semiconductor weakness. The $641 target delta highlights sell-side conviction that AMD is capturing durable share in hyperscaler accelerator budgets. Swing traders can watch for volume-confirmed breakouts above recent consolidation pivots as institutional desks accumulate.
Wells Fargo raised its price target on Marvell Technology (MRVL) to $310 from $240 while reiterating an Overweight rating on Monday, August 24. Analyst Aaron Rakers highlighted Marvell's custom ASIC contract win with Google, projecting a path to over $11 per share in EPS by fiscal 2029. Marvell reports Q2 2026 earnings on Thursday, August 27, with Wall Street expecting $2.709 billion in revenue (+35% Y/Y), supported by custom silicon agreements that could deliver up to $120 billion through fiscal 2033.
Why it matters
Wells Fargo's target hike anchors institutional sponsorship ahead of Thursday's earnings print, framing Marvell as the primary custom-silicon challenger to general-purpose GPU dominance. The Google custom chip contract provides a fundamental narrative shift that insulates MRVL from broader memory and optical supply-chain liquidation. Active traders should monitor whether post-earnings price action can break through multi-week resistance to trigger a high-volume continuation run.
Microsoft's tokenized equity (MSFT) trades near $483.70 on Monday, August 24, hugging its lower Bollinger Band with Stochastic %K at 19.72 and %D at 15.78. Derivatives telemetry shows retail and top Binance traders are heavily short-positioned at 59.1% and 59.0% respectively, building a crowded short base into structural support at $481.42. The washed-out technical profile comes despite underlying fundamental stability across Azure and enterprise AI adoption.
Why it matters
The convergence of deeply oversold short-term momentum oscillators and a heavily crowded short positioning base creates an asymmetric mean-reversion setup. When short interest accumulates near multi-week moving average support without downside price confirmation, any minor positive catalyst can spark a sharp short squeeze. Swing desks can define tight risk parameters directly below $481.42 to capture a rebound toward the 20-day EMA.
Building on the AI-to-energy rotation we've been monitoring, Bloom Energy (BE) extended its explosive 130% year-to-date run, climbing over 6% in pre-market action. The divergence against fuel cell peers like Plug Power (PLUG) widened as BE traded near $206, driven by new momentum: an up-to-2.8 GW onsite power agreement with Oracle and Brookfield's $25 billion financing framework. This fundamental expansion follows Q2 revenue that surged 165% to $1.06 billion and raised full-year guidance to between $3.9 billion and $4.2 billion.
Why it matters
Bloom Energy illustrates the aggressive monetization of onsite power generation as local grid interconnection delays become the primary bottleneck for AI datacenter buildouts. The sharp performance split against low-priced peers like PLUG demonstrates that institutional flows are strictly targeting high-scale solid oxide providers with contracted hyperscaler backlogs. Swing traders should treat BE as the primary vehicle for the datacenter power trade while managing risk against overbought technical readings.
Xylem Inc. (XYL) experienced unusual institutional options activity on Monday, August 24, featuring a 10,000-contract call spread targeting the September 18 expiration. Call volume outpaced puts by over 500-to-1, focusing on the $120 and $130 strike corridors where nearly all volume represented fresh open interest creation. Implied volatility rose modestly to 27.24% while 90/110 option skew declined to 3.02%, signaling institutional appetite for unhedged upside exposure.
Why it matters
Aggressive, concentrated call spread buying with a 500:1 call/put ratio provides an explicit footprint of institutional accumulation in a quiet industrial tape. The simultaneous drop in downside skew indicates smart money is positioning for orderly upside expansion rather than hedging against drawdowns. Swing traders can leverage this unusual options flow to align long entries with institutional sponsorship into the September expiration cycle.
Hardware Supply Chain Pre-Earnings Liquidation Optical networking (AAOI) and memory names (MU, SNDK) face steep, single-session liquidations as desks de-risk ahead of NVDA's print.
Trade Friction Defensive Flows The collapse of U.S.-Canada trade negotiations is triggering immediate capital inflows into domestic steel producers (STLD, NUE, CLF) protected by 50% tariff walls.
On-Site Power Expansion Momentum AI compute bottlenecks continue driving momentum into alternative power infrastructure, led by Bloom Energy's (BE) multi-gigawatt deals.
High-Beta Sell-Side Target Re-Anchoring Tier-1 sell-side desks are issuing aggressive price target hikes on large-cap tech leaders (AMD, MRVL, ADI) ahead of earnings catalysts.
Severe Binary Biotech De-Risking Regulatory holds and safety signals are sparking sharp single-day liquidations (RGNX) while clear BLA review paths spark aggressive re-ratings (CAPR).
What to Expect
2026-08-26—Nvidia, CrowdStrike, and Salesforce Q2 earnings reports alongside July PCE inflation print
2026-08-27—Marvell Technology and Iren Q2 earnings reports
2026-08-28—Fed Chair Kevin Warsh delivers keynote address at Jackson Hole Economic Policy Symposium
2026-09-08—Canada retaliatory tariffs against U.S. goods take effect
How We Built This Briefing
Every story, researched.
Every story verified across multiple sources before publication.
🔍
Scanned
Across multiple search engines and news databases
594
📖
Read in full
Every article opened, read, and evaluated
135
⭐
Published today
Ranked by importance and verified across sources
12
— The Tape Reader
🎙 Listen as a podcast
Subscribe in your favorite podcast app to get each new briefing delivered automatically as audio.
Apple Podcasts
Library tab → ••• menu → Follow a Show by URL → paste